Company intelligence / Profile preview

groninger

Crailsheim, Baden-Württemberg, Germanygroninger-group.com ↗

Ownership: Private
Employees: ~1600
Development stage: Commercial

Overview

Groninger does not conduct clinical trials or develop therapeutics. It manufactures advanced aseptic and automated fill-finish solutions for pharmaceutical and healthcare companies worldwide. Its technologies enable the safe and efficient production of small molecules, biologics, vaccines, cell/gene therapies, and more in compliance with GMP standards.

Therapeutic areas: OtherOncologyRare DiseasesInfectious Diseases
Modalities: Small moleculeBiologicAntibody-drug conjugateCell therapyGene therapyVaccineRecombinant protein
Industry: Medical Devices

Partnerships

SKAN AG – partnership on aseptic processing/fill-finish lines for over three decades; joint projects such as with Civica Rx in the US.

Beyond the preview

Go deeper on groninger.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on groninger.

Explore the full profile